Clinical Trials Logo
  1. Home
  2. Primary Hyperoxaluria Type 1
  3. NCT02830009

IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA — PH1  

Primary Hyperoxaluria Type 1 Clinical Trial

Clinical Trial Summary

The aim of this study is to know the difference between protein profiles (multi-analyte profile) of PH1 patients, idiopathic hypercalciuria (IH) patients and PH1 patients 'siblings. Idiopathic hypercalciuria is a less severe kidney disease that PH1, which also leads to the formation of kidney stones.

The aim is to identify patterns of discriminating markers associated with primary hyperoxaluria type 1 (PH1) that will significantly improve clinical diagnosis and prognosis.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02830009
Study type Interventional
Source Hospices Civils de Lyon
Contact
Status Completed
Phase N/A
Start date May 2013
Completion date December 2015
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Terminated NCT02795325 - A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1) Phase 1
Completed NCT03067142 - Proteomics of Primary Hyperoxaluria Type 1
Active, not recruiting NCT04152200 - A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 Phase 3
Recruiting NCT05001269 - Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function Phase 2
Recruiting NCT04982393 - BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
Recruiting NCT04580420 - Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD Phase 2